DM BioValues (DELFIA) – Content
DM BioValues (DELFIA) is an advanced immunoassay-based testing platform utilizing DELFIA (Dissociation-Enhanced Lanthanide Fluorescence Immunoassay) technology. DELFIA uses time-resolved fluorescence with lanthanide-based labels such as Europium to provide highly sensitive and robust detection.
What is it used for?
DM BioValues (DELFIA) testing can support accurate quantitative analysis of various biomarkers and immunological analytes, depending on the specific assay available.
Key Advantages
- High analytical sensitivity
- Wide dynamic range
- Excellent signal-to-background ratio
- Robust and reproducible assay performance
- Time-resolved fluorescence technology helps reduce background interference
- Suitable for a range of immunoassay formats, including sandwich and competitive assays
Clinical Applications
DELFIA-based platforms are widely used in areas such as:
- Prenatal screening
- Neonatal screening
- Hormonal and endocrine testing
- Pregnancy-related biomarkers
- Other specialized immunoassays, depending on the laboratory's test menu.
Why Choose DM BioValues (DELFIA)?
Advanced fluorescence-based technology provides sensitive and reliable biomarker measurement, supporting clinicians in screening, diagnosis, and patient monitoring.
Sample: Typically serum/plasma or other specimen types depending on the specific assay.
Note: The exact test parameters, specimen requirements, reference ranges, and clinical interpretation depend on the individual DELFIA assay.